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Abstract 
Neural respiratory drive, i.e., the activity of respiratory centres controlling breathing, is an overlooked physiologic 
variable which affects the pathophysiology and the clinical outcome of acute respiratory distress syndrome (ARDS). 
Spontaneous breathing may offer multiple physiologic benefits in these patients, including decreased need for 
sedation, preserved diaphragm activity and improved cardiovascular function. However, excessive effort to breathe 
due to high respiratory drive may lead to patient self-inflicted lung injury (P-SILI), even in the absence of mechanical 
ventilation. In the present review, we focus on the physiological and clinical implications of control of respiratory drive 
in ARDS patients. We summarize the main determinants of neural respiratory drive and the mechanisms involved in 
its potentiation, in health and ARDS. We also describe potential and pitfalls of the available bedside methods for drive 
assessment and explore classical and more “futuristic” interventions to control drive in ARDS patients.
Determinants of respiratory drive
Healthy subjects
Breathing is generated by the rhythmic discharge of 
groups of neurons located in the brainstem which pro-
duces a neural signal directed to respiratory muscles to 
generate inspiratory effort and tidal breathing [1, 2]. In 
humans, the activity of the respiratory centres requires 
a tonic excitatory input that derives from two sources: a 
chemosensory or “automatic” input and a descending or 
“behavioural” input.
The chemosensory input is a feedback reflex medi-
ated by afferents from central and peripheral chemore-
ceptors aimed at minimizing fluctuations of the partial 
pressure of arterial carbon dioxide  (PaCO2) and pH and 
correcting hypoxemia. Central chemoreceptors, located 
in the ventral surface of the medulla oblongata, regulate 
the ventilatory response to stabilize  CO2: an increase in 
 PaCO2, by decreasing the pH of cerebrospinal fluid, leads 
to a linear increase in minute ventilation until steady-
state is achieved after a few minutes [3]. The peripheral 
chemoreceptors, located in the carotid bodies, stimulate 
breathing by modifying the sensitivity and threshold of 
the central chemoreceptors, specifically providing faster 
and more intense responses to modifications in  PaCO2 
and pH and to hypoxemia [3–5].
The descending input is a feed-forward pathway from 
cortical brain centres and is responsible for adaptive 
changes of breathing pattern during complex activities, 
such as physical exercise and mental tasks [6, 7]. Both 
the chemosensory and the central input are active in 
awake healthy subjects [8, 9]. Indeed, artificially induced 
hypocapnia (e.g., through mechanical ventilation) does 
not abolish respiratory drive [9]. In addition, the res-
piratory rhythm is modulated by signals from the limbic 
system, which alters the breathing pattern in response to 
cognitive and emotional factors, including pain and anxi-
ety [10].
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In physiological studies, the response of the subject 
to raised  PaCO2 level is assessed by measuring the 
increase in minute ventilation. In this context, two 
curves exist: the “brain curve”, that describes the min-
ute ventilation requested by the neural respiratory 
drive for a given  PaCO2; and the “ventilation curve”, 
that describes the actual minute ventilation of the sub-
ject for a given  PaCO2. In health, the brain curve coin-
cides with the ventilation curve. The levels of  PaCO2 
and the corresponding minute ventilation show a linear 
correlation, the slope of which represents the “brain” 
respiratory drive [11]. The actual point of equilibrium 
will lie at the intersection between this neural drive and 
the metabolic hyperbola, which, instead, is the relation-
ship between ventilation and the resultant  PaCO2 for 
a given level of metabolic  CO2 production and dead 
space [11, 12] (Fig. 1a).
Acute respiratory distress syndrome
The brain curve, the ventilation curve and the metabolic 
hyperbola are all potentially modified in ARDS: increased 
dead space and metabolic  CO2 production shift the met-
abolic hyperbola upward, meaning that  PaCO2 is higher 
than normal for a given minute ventilation [11]; the 
slopes and the position of the brain curve and the ventila-
tion curve are altered in opposite directions (Fig. 1b).
In ARDS, pulmonary interstitial and alveolar edema 
result in increased intra-pulmonary shunt and dead 
space, and decreased functional lung size due to alveo-
lar collapse (the so-called “baby lung”) [13]. Systemic 
Fig. 1 Metabolic hyperbola, brain and ventilation curves in health and ARDS. The metabolic hyperbola is the relationship between ventilation and 
the resultant  PaCO2 for a given level of metabolic  CO2 production and dead space. Increased dead space or  CO2 production will shift the hyperbola 
up. The ventilation curve describes the actual effect of changing  PaCO2 on resultant minute ventilation. ARDS can shift the ventilation curve to the 
right (lower minute ventilation despite higher  PaCO2) due to increased respiratory load and muscle weakness. Finally, the brain curve (also known as 
the "controller curve", "CO2 sensitivity curve" or "ventilation gain curve") describes the minute ventilation theoretically requested by the neural res-
piratory drive for a given  PaCO2. During ARDS, this is shifted to the left (higher minute ventilation despite lower  PaCO2) due to multiple concomitant 
pathologic conditions, including acidosis, inflammation and others. a In health, brain and ventilation curves overlap and the ventilation response 
(i.e., the change in minute ventilation induced by a change in  PaCO2) reflects the neural respiratory drive. The metabolic hyperbola is obtained 
assuming a dead space of 0.3 and a metabolic  CO2 production  (VCO2) of 200 ml/min. Brain and ventilation curves are overlapping and are calcu-
lated assuming at  PaCO2 of 39.5 mmHg, a ventilation of 6.5 l/min, linearly increasing to 30 l/min at a  PaCO2 of 49 mmHg. b In ARDS, the metabolic 
hyperbola is shifted upward due to increase of dead space (0.5) and  VCO2 (250 ml/min). The listed factors cause the brain and ventilation curves 
to be shifted in opposite directions and diverge. Please, note that a single ARDS patient will be characterized by both curves at the same time: the 
brain curve will correspond to the theoretical ventilation/PaCO2 correlation desired by the neural respiratory drive, while the ventilation curve will 
be the actual ventilation/PaCO2 correlation measured by spirometer and blood gas analysis. Brain and ventilation curves are calculated assuming a 
ventilation of 6.5 l/min at 28 mmHg  PaCO2 (increasing to 30 l/min at 33 mmHg  PaCO2) and a ventilation of 5 l/min at 40 mmHg  PaCO2 (increasing to 
25 l/min at 52 mmHg  PaCO2), respectively
inflammation is common and extra-pulmonary organ 
dysfunction frequently develops (Fig. 2).
Impairment of gas exchange leads to an increase in 
chemosensory input. Increase in  PaCO2, promoted by 
high dead space, induces a linear increase in respira-
tory drive through both central and peripheral chemo-
receptors [14, 15]. On the other hand, the ventilatory 
response following severe hypoxemia typical of ARDS is 
not linear but hyperbolic [11]. Peripheral chemorecep-
tors, which are relatively insensitive at mild hypoxemia, 
increase the neural respiratory drive in response to more 
severe hypoxemia, mainly by enhancing the ventilatory 
response to  CO2 when the partial pressure of arterial 
oxygen  (PaO2) falls below 60–70 mmHg. This effect can 
be potentiated by concomitant hypercapnia. Metabolic 
acidosis, which frequently complicates ARDS because of 
shock or acute kidney injury, stimulates both peripheral 
and central chemoreceptors [16].
In addition, ARDS might be associated with altera-
tions of neural respiratory drive induced by mechanisms 
specifically associated with lung inflammation and 
altered mechanics. In awake spontaneously breath-
ing rats, ARDS induces an increase in respiratory rate 
occurring before impairment of gas exchange. Hypoxic 
ventilatory response is also exaggerated due to a sensi-
tization of peripheral chemoreceptors [17]. Local and 
systemic inflammation are hallmarks of ARDS [18], and 
pulmonary C-fibers sensitive to inflammatory mediators 
(including histamine, bradykinin and prostaglandins) 
are consistently activated in lung edema [19] and experi-
mental acute lung injury [20]. Vagal afferents from these 
lung chemoreceptors can modulate the breathing pattern 
through a central reflex pathway [21]. The consequence 
of vagal activation is an increase in respiratory rate with 
a decrease in tidal volume, i.e., rapid shallow breathing 
[22, 23], possibly through vagally mediated release of 
cytokines in the brainstem [24].
The lung also contains mechanoreceptors: slowly 
adapting receptors (SARs) are stretch receptors activated 
by lung inflation that inhibit central chemoreceptors in 
Fig. 2 Schematic representation of control of respiratory drive in ARDS. The figure shows the key triggers of respiratory drive and the anatomic tar-
gets where these triggers exert their effects. In the centre, the descending cascade from neural respiratory drive to breathing effort and lung stress 
is represented, together with the main factors that may cause a dissociation between drive and effort (i.e., muscle function) and between drive, 
effort and lung stress (i.e., neuromechanical coupling and respiratory mechanics)
rats (for example during the Hering-Breuer reflex), ter-
minating inspiration. Although the Hering-Breuer reflex 
might be inhibited by the behavioural control of breath-
ing in awake humans [25], decreased inhibitory input 
from these mechanoreceptors in the atelectatic lung 
could promote a further increase in inspiratory effort 
in ARDS. Indeed, the activation of mechanoreceptors 
appears to decrease as ARDS develops [20], while it is 
increased by increasing positive end-expiratory pressure 
(PEEP) [26], probably through stabilized lung recruit-
ment. This could be one of the mechanisms by which 
high PEEP decreases spontaneous respiratory effort 
in ARDS [27]. Stimulation of the respiratory centres 
through each of these mechanisms increases the slope—
and shift to the left—of the brain curve. Decreases in lung 
and chest wall compliance increase the elastic load and 
can alter the neuro-mechanical coupling between effort 
and diaphragmatic excursion. The result is a decreased 
slope of the ventilation curve and an increase in  PaCO2, 
which induces a stimulation of neural respiratory drive 
and a dissociation between brain and ventilation curves 
(Fig. 3).
Pain, anxiety and discomfort are common in ARDS 
patients and all can influence drive. Emotional responses 
may affect the brain curve independent of a patient’s 
metabolic demands: anxiety and fear act through the 
forebrain, limbic and cortical structures and the hypo-
thalamus, processing information from the external 
environment and directly stimulating spinal respiratory 
motor neurons [10, 28]. Pain affects the respiratory drive 
through both behavioural responses and a direct reflex 
on medullary respiratory centres [28]. On the other hand, 
the use of sedatives might decrease the neural respiratory 
drive [29].
Poor patient–ventilator interaction is another deter-
minant of drive in subjects with ARDS on mechanical 
ventilation. Dyssynchronies might increase the respira-
tory drive because they cause discomfort and increased 
respiratory load [30]. Mismatch between the timing and 
duration of mechanical inflation and the neural inspira-
tory time prevents effective unloading of the respiratory 
muscles during assisted ventilation. Moreover, air trap-
ping, which may occur during protective ventilation in 
ARDS due to the high respiratory rate, could cause addi-
tional inspiratory load and delayed trigger, both of which 
can increase drive.
Of note, the more severe the lung injury, the higher the 
inspiratory effort reflecting increased activation of neural 
respiratory drive [31].
How to assess respiratory drive at the bedside
A fundamental difference between ARDS patients and 
healthy subjects is that ventilatory response may not 
(and usually does not) mirror the respiratory drive [11]. 
The alterations in neuromuscular function (muscle 
weakness) and respiratory mechanics (atelectasis and 
increased lung and chest wall elastance) generate a dis-
crepancy between the activity of the respiratory centres 
Fig. 3 Potential dissociation between neural respiratory drive (P0.1) and respiratory effort (Pes) under pathologic conditions. The figure shows simu-
lated identical waveforms for airway pressure (Paw) during supported breaths but with different simulated oesophageal pressure (Pes) waveforms. 
P0.1 (i.e., the negative airway pressure generated by occlusion occurring during the first 0.1 s of an inspiration) reflects the intensity of neural respira-
tory drive. Oesophageal pressure swings (ΔPes) allow quantification of respiratory effort. However, in patients with high chest wall elastance, ΔPes 
underestimates effort. In the presence of muscular weakness, high drive may be associated with “normal” or even low effort (right panel)
and the resulting motor output. When the intensity of 
the signal from the brain to the muscles and to the lung 
is dampened by these alterations, the force of contrac-
tion of respiratory muscles and the changes in intratho-
racic pressure, flow and volume underestimate the neural 
drive. Therefore, clinical surrogates of respiratory drive 
may be conveniently categorized according to their “dis-
tance” from the respiratory centres (Table 1). First, neural 
output (i.e., electrical activity of the diaphragm); second, 
breathing effort, assessed by changes in pressure induced 
by the respiratory muscles (i.e., swings in pleural pressure 
or P0.1); and, third, ventilatory response, reflected by the 
tidal volume and respiratory rate (breathing pattern).
Neural output
The electrical activity of the crural diaphragm (EAdi) 
reflects the phrenic nerve activity and hence the neu-
ral output of the respiratory centres to the diaphragm, 
provided that neuromuscular transmission and muscle 
excitability are intact. Eadi may be recorded using an 
oesophageal catheter with multiple electrodes and it rep-
resents the “closest” surrogate of neural respiratory drive 
available in clinical practice [32]. Because of high inter-
individual variability, it is difficult to provide references 
for absolute values of EAdi [33]. However, trends in EAdi 
allow the tracking of changes in neural output in individ-
ual patients [34]. EAdi is also increased in the presence of 
low muscle strength [35] and the ratio of actual EAdi to 
maximum EAdi measured during an occlusion may pro-
vide an accurate estimate of the patient neural respira-
tory drive and effort to breathe [33]. The ratio between 
tidal volume (Vt) and EAdi represents the neuroventila-
tory efficiency of the diaphragm [36]: a low Vt/EAdi ratio, 
either due to diaphragm dysfunction or to compromised 
respiratory mechanics, indicates dissociation between 
neural respiratory drive and ventilatory response. EAdi 
monitoring only assesses the activity of the diaphragm. 
However, recruitment of accessory inspiratory [37] 
and expiratory [38, 39] muscles is a strong indicator of 
increased neural respiratory drive due to a mismatch 
between the respiratory load and the muscle capacity 
with decreased expiratory time. Surface electromyogra-
phy of extra-diaphragmatic respiratory muscles could, 
therefore, integrate the EAdi for a complete assessment 
of neural respiratory drive [40].
Breathing effort
Indices based on the pressure developed by the res-
piratory muscles, such as oesophageal pressure swings 
(ΔPes) and respiratory muscle pressure (Pmus), allow reli-
able quantification of inspiratory effort determined by 
the neural respiratory drive [41]. Even though ΔPes at 
increasing PEEP levels did not correlate with changes in 
the electrical activity of the diaphragm in ARDS patients 
in one study [27], driving transpulmonary pressure dur-
ing active inspiration largely depends on ΔPes in presence 
of high respiratory effort and could be quite difficult to 
predict when monitoring only the airway pressure [42]. 
The pressure generated by the respiratory muscles (Pmus) 
is computed as the difference between the static recoil 
pressure of the chest wall and ΔPes. Pmus values higher 
than 10  cmH2O might indicate high effort [43]. The nega-
tive airway pressure generated by occlusion occurring 
during the first 0.1  s of an inspiration, known as P0.1, is 
commonly used as an index of respiratory drive [44]. In 
healthy subjects, P0.1 varies between 0.5 and 1.5  cmH2O. 
P0.1 values consistently above 3–4  cmH2O indicate high 
neural respiratory drive and high work of breathing [45, 
46]. P0.1 depends on the integrity of neuromuscular trans-
mission. However, as compared with other indices based 
on breathing effort, it is not affected by moderate reduc-
tions of respiratory muscle strength, therefore, represent-
ing a reliable index of respiratory drive even in patients 
with muscular weakness [47].
Breathing pattern
Interpretation of the breathing pattern as a surrogate 
for respiratory drive is challenging in ARDS patients. In 
healthy subjects, increases in ventilatory demand are met 
by initial increases in Vt with constant inspiratory time 
(Ti), resulting in high mean inspiratory flow (Vt/Ti), that 
reflects high drive [48–50]. Similarly, high Vt (and high 
Vt/Ti) in spontaneously breathing patients with ARDS 
suggest dangerous increases in respiratory drive both 
during noninvasive [51] and invasive mechanical venti-
lation [52]. Increased respiratory rate occurs only when 
respiratory drive is three to four times higher than nor-
mal and it is detected by an increased ratio of Ti and total 
breath duration (Ti/Ttot) [49, 50]. However, decreased 
respiratory compliance [53] and muscular weakness may 
limit the increase in Vt in ARDS [54]. Increased neural 
respiratory drive could then lead to early increases in res-
piratory rate with decreased Ti [55] and the rapid shallow 
breathing index (respiratory rate divided by tidal volume) 
[56] might indicate high drive with unsatisfied ventilatory 
demand.
Finally, high respiratory drive due to mechanical load 
or metabolic demand results in a reduction of the physi-
ologic variability of breathing [57].
As a “gold standard” for clinical evaluation of respira-
tory drive is lacking, multilevel assessment might be the 
most informative approach. While measurements closer 
to the brain centres more reliably reflect the neural drive, 
downstream parameters (namely the amplitude and the 
rate of changes in lung volume and pressure that result in 
ventilation) provide information about the magnitude of 
lung stress generated by spontaneous ventilation, which 
is the determinant of P-SILI [58]. Dyspnea results from 
the imbalance between load and muscle capacity or from 
the imbalance between motor output and lung expansion 
[59]. The complex neural network involved in dyspnea 
receives afferent information on the respiratory motor 
output from the brainstem and the motor cortex [60], as 
well as multiple sensory feedbacks from the chemore-
ceptors and the mechanoreceptors of the lung and chest 
wall [61]. The perception of dyspnea depends on the 
integration of this motor and sensory information, mod-
ulated by emotion [62]. Therefore, bedside assessment of 
dyspnea could allow estimation of the distance between 
brain and ventilation curves.
Table 1 Monitoring tools for respiratory drive
EAdi electrical activity of the crural diaphragm, P0.1 airway occlusion pressure, Pes oesophageal pressure, Pmus pressure generated by the respiratory muscles, RSBI rapid 
shallow breathing index, Vt tidal volume, Ti inspiratory time
a Indices based on neural output more closely reflect the neural respiratory drive. However, they might be dissociated from breathing effort and ventilatory response 
due to neuromuscular dysfunction or compromised respiratory mechanics. “Downstream” indices (based on breathing effort and ventilatory response) might 
underestimate the neural respiratory drive, but more closely reflect the potentially detrimental effects of drive on lung injury
Parametera Physiological 
level
Monitoring tool Advantages Limitations
EAdi Neural output Oesophageal catheter with 
electrodes
Close to neural drive [32]; tracks 
changes in neural drive (due to 
changes in diaphragm function, 
respiratory mechanics or ventila-
tory assistance) [34, 35]
Inter-individual variability [33]; 
assesses only diaphragm activity; 
available only on one type of 
ventilator [32]
Electromyography Neural output Surface electrodes Assessment of the activity of 
diaphragm and extra-diaphrag-
matic muscles
Technically demanding; not rou-
tinely available
P0.1 Breathing 
effort
Ventilator Automatic measurement available 
on some ventilators; not affected 
by respiratory mechanics [44] 
and moderate muscle weakness 
[47]; good correlation with work 
of breathing [44]
Breath-to-breath variability; indirect 
measure in some ventilators; 
accuracy of absolute values varies 
according to the ventilator mode
Dyspnea Neural output 
and breath-
ing effort
Guided questions, visual scales, 
clinical assessment (e.g., Respira-
tory Distress Observation Scale)
Comprehensive parameter; may 
reflect the distance between 
brain and ventilation curve [59, 
62]
Relies on patient collaboration and 
ability to communicate; affected 
by emotional and cognitive fac-
tors (pain, anxiety, delirium, etc.) 
[59]
Oesophageal pressure 
swings
Breathing 
effort
Oesophageal manometry Estimates contributions of extra-
diaphragmatic muscles [41]
Insensitive to the effort required to 
expand the chest wall; affected by 
muscle function [41]
Pmus Breathing 
effort
Oesophageal manometry Best indicator of effort, well corre-
lated with work of breathing [43]
Requires measurement of elastic 
chest wall recoil pressure under 
passive conditions; affected by 
muscle function
Use of accessory 
inspiratory and 
expiratory muscles
Breathing 
effort
Visual inspection Assessment of the activity of extra-
diaphragmatic muscles [37]
High inter-observer variability, quali-
tative assessment [37, 38]; affected 
by muscle function
Respiratory Rate Ventilatory 
response
Ventilator or visual inspection Easy to assess at the bedside Inter-individual variability in values 
at rest and during stress [50]; 
affected by respiratory mechanics, 
muscle function [53–55], pain and 
emotional state
RSBI Ventilatory 
response
Ventilator Easy to assess at the bedside Affected by respiratory mechanics 
and muscle function; developed 
as a predictor of weaning failure 
and not as a surrogate for drive
Mean inspiratory flow 
(Vt/Ti)
Ventilatory 
response
Ventilator/oesophageal catheter 
with electrodes or manometry
High Vt/Ti consistently reflects 
high drive [48–50]
Neural inspiratory time requires EAdi 
[32]; affected by muscle function
Clinical impact of abnormal respiratory drive 
in subjects with ARDS
Physiological and clinical consequences of high respiratory 
drive
Use of partially supported modes of ventilation in 
ARDS patients could entail the advantage of decreas-
ing sedation, improving hemodynamics and preserving 
respiratory muscle function. However, indications for 
preserving or restoring spontaneous breathing in patients 
with ARDS are still controversial because, if respiratory 
drive is not controlled and causes vigorous spontaneous 
breathing efforts, this worsens lung and diaphragm injury 
[31, 63, 64].
The mechanisms underlying additional lung injury 
due to elevated efforts are multiple and complementary. 
High transpulmonary pressure during inspiration and 
large tidal volumes determine an increase in lung stress 
and strain. Patient–ventilator asynchronies due to high 
inspiratory effort such as double triggering can also lead 
to high tidal volume [65]. Even in the presence of pro-
tective Vt and pressure, regional injury can still occur 
because of increased local stress in dependent atelec-
tatic lung regions due to the solid-like behaviour of the 
diseased lung. In addition, decrease of pleural pressure 
generated by diaphragmatic contraction is larger in the 
dependent lung regions drawing air from non-dependent 
regions before ventilator flow reaches the alveoli (i.e., 
occult pendelluft phenomenon) [66]. Distribution of tidal 
volume within the lungs is usually more homogenous 
during spontaneous breathing as compared to controlled 
ventilation, but too high effort can lead to ventilation het-
erogeneity with a larger portion of tidal volumes reach-
ing dependent regions. The increased negative pleural 
pressure during forceful breathing effort also increases 
transmural vascular pressure, which promotes additional 
pulmonary oedema due to increased lung perfusion and 
lower alveolar pressure [67].
Few animal experimental studies show that high inspir-
atory effort due to excess inspiratory load might induce 
diaphragm inflammation [68, 69] and promote dia-
phragm injury [70].
The clinical impact of these mechanisms still needs to 
be fully defined. From the lung injury point of view, stud-
ies on the effects of early use of neuromuscular blocking 
agents in ARDS are controversial [52] and a few pilot 
articles reported beneficial effects of preserved spontane-
ous breathing versus controlled ventilation on lung aera-
tion [39]. As far as diaphragm function is concerned, a 
small clinical study in critically ill patients reported that 
high inspiratory effort may lead to increased diaphragm 
thickness (which might reflect structural injury) and to 
prolonged mechanical ventilation [71].
Modulating the respiratory drive in the clinical setting
Ideally, control of respiratory drive in ARDS should 
reduce the dissociation between brain and ventilation 
curves [11]. High respiratory drive might be considered 
“appropriate” when the activating stimulus can be cor-
rected by increased ventilatory response. This is the case 
for hypercapnia and hypoxemia. Increased ventilation is 
the physiologic response aimed at correcting these altera-
tions. Conversely, several stimuli that increase the activ-
ity of respiratory centres in ARDS are not modified by the 
ventilation feedback. For example, inflammation, pain 
and anxiety induce an “inappropriate” high respiratory 
drive. In the case of an appropriate high neural respira-
tory drive, the treatment should facilitate the ventilatory 
response (for example by increasing ventilatory support); 
on the other hand, inappropriate high drive requires a 
specific treatment (for example medications for anxi-
olysis). In the context of ARDS, the effects on the lung 
should always be monitored and high respiratory drive, 
either appropriate or inappropriate, should be controlled 
if it results in the generation of excessive lung stress with 
consequent increased in the risk of P-SILI.
Multiple strategies are available to modulate the res-
piratory drive and/or effort in ARDS patients, according 
to the underlying causes and mechanisms of increased 
drive (Table 2). These include respiratory support modes 
and settings, medications and non-pharmacologic 
interventions.
Interventions for control of respiratory drive
Non‑invasive respiratory support
Increased respiratory drive is a hallmark of acute res-
piratory failure from the outset, with the acute onset of 
dyspnea as the main presenting symptom [58]. The rec-
ommended initial management may now include vari-
ous forms of non-invasive respiratory support: nasal high 
flow (NHF) [72], continuous positive airway pressure 
(CPAP) and non-invasive positive pressure ventilation 
(NIV) [73]. These options can directly modulate the res-
piratory drive, albeit by different mechanisms, generating 
relevant clinical consequences (Table 3).
NHF may reduce drive by wash-out of  CO2 from upper 
airways, decreased  CO2 production following decreased 
inspiratory effort, improved oxygenation and improved 
dynamic lung compliance [74].
CPAP potentially modulates drive by improving oxy-
genation by means of positive airway pressure, optimised 
oxygen delivery and improvement of lung mechanics 
[75].
NIV may decrease respiratory drive by several mech-
anisms: unloading respiratory muscles from inspira-
tory effort, which also reduces  CO2 production; as well 
as improving oxygenation and lung mechanics through 
increases in PEEP [76].
However, these effects may be mitigated by competing 
physiologic effects. CPAP can lead to  CO2 re-breathing 
and decreased efficiency of  CO2 clearance that could 
diminish the positive effects on respiratory drive. During 
NIV, patient intolerance or air leaks may result in inter-
mittent mask removal and promote patient–ventilator 
dyssynchrony, which, in turn, could increase respiratory 
drive by discomfort and sleep disruption. Finally, NIV 
unloads the respiratory muscles by applying positive 
airway pressure during inspiration, which could lead to 
unchanged or even increased transpulmonary pressure 
and additional lung injury [77].
Invasive mechanical ventilation
When invasive mechanical ventilation is instituted, 
there is often an initial phase of deep sedation, which 
may decrease the respiratory drive and, occasionally, 
a period of neuromuscular blockade, which eliminates 
breathing effort. Once assisted breathing is restored, 
uncontrolled high respiratory drive may resume as well 
[63]. In this context, the choice of ventilation mode 
and settings should aim at decreasing the dissociation 
between the brain and ventilation curves, while limit-
ing risks of additional lung injury. When the ventilatory 
response corresponds to the neural respiratory drive, 
controlling drive is crucial to ensure lung protection. 
On the other hand, in the presence of a large disso-
ciation between the brain and ventilation curves, lung 
protection could be maintained even in the presence of 
increased neural respiratory drive; however, adjusting 
settings to decrease this dissociation could have addi-
tional benefits like improving dyspnea and prevent-
ing abnormal breathing patterns (e.g., rapid shallow 
breathing).
The most commonly used assisted ventilation modes 
are pressure/volume assist control and pressure support. 
During assist control, higher peak inspiratory flow deliv-
ered by pressure-based mode might better match the 
need of dyspneic ARDS subjects and mitigate drive, but, 
at the same time, presence of high inspiratory drive could 
lead to high tidal volumes, which are not lung-protective. 
On the other hand, volume assist control allows precise 
control of set tidal volume and driving transpulmonary 
pressure independent of the patient’s drive, but, high 
drive can still generate occult pendelluft and regional 
overdistension [65].
Table 2 Determinants of increased respiratory drive in ARDS, associated mechanisms and potential interventions to con-
trol drive
ARDS acute respiratory distress syndrome, CO2 carbon dioxide, DO2 oxygen delivery, ECCO2R extracorporeal  CO2 removal, ECMO extracorporeal membrane 
oxygenation, FiO2 fraction of inspired oxygen, PEEP positive end-expiratory pressure, P-SILI patient self-inflicted lung injury, RRT renal replacement therapy, VO2 
oxygen consumption, V/Q ventilation/perfusion
Determinant Common etiologies Mechanisms Potential interventions (as appropriate)
Hypercapnia ↑ Dead space, ↑ lung and chest 
wall elastance, ↑  CO2 produc-
tion
Stimulation of central and peripheral chemorecep-
tors [3, 5, 14, 15]
Ventilatory support; fever and pain control; 
sedation;  ECCO2R [95]
Hypoxemia ↑ Intrapulmonary shunt, V/Q 
mismatch, ↑  VO2/DO2
Stimulation of peripheral chemoreceptors [4, 16] FiO2 [78, 79], PEEP [26, 27]; mechanical 
ventilation cardiovascular support (fluids, 
inotropes, vasopressors, red cell transfu-
sion); ECMO
Metabolic 
acidosis
Shock, acute kidney injury Stimulation of central and peripheral chemorecep-
tors [16]
Cardiovascular support; bicarbonate; RRT 
Inflammation ARDS, P-SILI, sepsis Increased sensitivity of peripheral chemoreceptors 
to hypoxemia; stimulation of lung chemore-
ceptors (C-fibers) [19–21]; direct stimulation of 
respiratory centres by cytokines [24]
Aetiologic treatment; lung- and diaphragm-
protective mechanical ventilatory support
Lung atelec-
tasis
Pulmonary edema, inflammatory 
cells, re-absorption atelectasis
↓ Inhibitory activity from lung slow adapting 
mechanoreceptors [20]
PEEP [26, 27] and respiratory support; prone 
positioning; physiotherapy
Agitation Anxiety, pain, respiratory distress ↑ Descending input [28] Respiratory support; sedation or anxiolysis; 
non-pharmacologic (and potentially phar-
macologic) treatments of delirium [93, 94]
Poor patient–
ventilator 
interaction
↑ Lung and chest wall elastance 
leading to flow starvation and 
increased inspiratory load; 
intrinsic PEEP causing delayed 
triggering
↑ Descending input due to discomfort; ↑ inspira-
tory load due to mismatch between mechanical 
inflation and
neural inspiratory time [30]; stimulation of central 
and
peripheral chemoreceptors in the case of hyper-
capnia
Adjust ventilation settings, change ventila-
tion modes [80–82], titrate sedation, 
consider neuromuscular blockade [58]
During PSV, simple settings such as the support level, 
PEEP and  FiO2 [78, 79] could influence the respiratory 
drive. Potential mechanisms of benefit include unload-
ing of the respiratory muscles, improved mechanics and 
better oxygenation. Oppositely, the drive increases when 
the ventilator support is reduced. However, unprotec-
tive levels of ventilation should not be tolerated in order 
to comply with the patient respiratory drive during PSV: 
switching back to controlled ventilation might be safer 
when inspiratory plateau pressure is higher than 30 
 cmH2O, Vt greater than 6–8 ml/kg predicted body weight 
and high levels of  FiO2 (e.g., > 80%) are needed [58]. 
Alternative modes of assisted ventilation with non-fixed 
support proportional to diaphragm electrical activity [80] 
or to a desired range of work of breathing performed by 
the patient [81] are emerging as possibly safer alterna-
tives to increase support without risking excessive addi-
tional lung injury. Indeed, during these modes, the drive 
decreases when support by the ventilator is increased, 
but, at the same time, the Vt and inspiratory pressure 
increases only up to a point below safe thresholds, likely 
because of preserved reflexes limiting lung volumes. 
Finally, artificially introducing some variability within 
the respiratory pattern by noisy pressure support [82] or 
by cyclic large breaths (i.e., using “sighs”) [83] has been 
shown to safely modulate increased respiratory drive, 
by improving oxygenation or respiratory mechanics, or 
through the Hering–Breuer effect, or all the above.
Airway pressure-release ventilation (APRV) is a mode 
that allows unsupported spontaneous breaths at two 
pressure levels (low and high) [84]. When APRV is set 
with a relatively low rate (10–12 bpm) and an inspiratory-
to-expiratory (I:E) ratio of 1:1–1:0.8, the non-synchro-
nized mandatory pressure changes generate mechanical 
breaths that could relieve the patient’s respiratory drive 
and also be used to estimate the pressure generated by 
spontaneous breaths (e.g., similar delta pressure for simi-
lar Vt) [85].
Pharmacological interventions
Medications that may induce respiratory depression are 
commonly used for analgo-sedation in ICU patients. 
However, as most of these medications are associated 
with short- and long-term adverse effects, their use 
should be minimized and their effects closely monitored. 
Use of sedatives or analgesics for the sole purpose of 
Table 3 Physiologic effects of different modes of non-invasive and invasive respiratory support and ventilation
PL transpulmonary pressure, FiO2 fraction of inspired oxygen, PEEP positive end-expiratory pressure, HFNC high flow nasal cannula, CO2 carbon dioxide, CPAP 
continuous positive airway pressure, NIV non invasive ventilation, PSV pressure support ventilation, APRV airway pressure release ventilation, MV mechanical 
ventilation, Vt tidal volume, DP driving pressure
Neural drive Mechanisms 
decreasing drive
Mechanisms 
increasing drive
Driving  PL Mechanisms 
decreasing driv‑
ing PL
Mechanisms 
increasing driv‑
ing PL
Non-invasive support
  Venturi mask High Increased set  FiO2 Lung collapse, 
hypoxemia
High – High effort and 
poor respiratory 
mechanics
  HFNC Reduced Increased alveolar 
 FiO2, small PEEP 
effect,  CO2 
washout
Residual lung col-
lapse
Decreased Decreased effort Poor respiratory 
mechanics
  Helmet CPAP Reduced Higher PEEP CO2 rebreathing Unchanged or 
increased
Improved respira-
tory mechanics
High effort
  NIV From high to almost 
suppressed
Higher PEEP, 
positive pressure 
support
Discomfort Increased Improved respira-
tory mechanics
Positive airway pres-
sure during inspi-
ration + residual 
effort
Invasive ventilation
  PSV From high to almost 
suppressed
Higher PEEP, 
positive pressure 
support
Asynchronies, 
discomfort, poor 
patient–ventilator 
flows matching
Normal to high Improved respira-
tory mechanics
Positive airway pres-
sure during inspi-
ration + residual 
effort
  APRV Reduced Higher PEEP, man-
datory breaths
Discomfort, low Vt Decreased Improved respira-
tory mechanics, 
decreased effort
High effort
  Assist/
 control MV
Low Higher PEEP, fixed Vt 
or DP
Asynchronies, dis-
comfort, low Vt
Normal to high Improved respira-
tory mechanics
Positive airway pres-
sure during inspi-
ration + residual 
effort
control of respiratory drive may be disadvantageous. It 
might be more appropriate to look first for the main rea-
son leading to increased respiratory drive (e.g., “fighting 
the ventilator” or pain) and choose the medication that 
specifically targets it.
Pain medications
Respiratory depression induced by opioids has long been 
recognized. A study from 1975 on subcutaneous mor-
phine administered to healthy subjects [86], demon-
strated altered ventilatory response to hypercapnia, with 
decreased slope of the minute ventilation/PaCO2 curve. 
High doses of intravenous opioids decrease the electrical 
activity of the inspiratory muscles in opioid-tolerant sub-
ject [87]. Opioids are widely used in the ICU for analgo-
sedation but only few studies have assessed their effects 
on respiratory drive. Remifentanyl decreases respiratory 
rate and increases expiratory timer without modifying 
EAdi in critically ill patients on assisted ventilation [88]. 
Reasons for this limited effect might be the use of lower 
doses compared with those used by opioid abusers and/
or the increased respiratory drive of critically ill patients. 
Thus, opioids might be of limited value for controlling 
respiratory drive and the risk of P-SILI in ARDS patients.
Drugs modulating agitation and anxiety
Both intravenous and inhaled general anaesthetics reduce 
the respiratory drive and have been tested in intubated 
ICU patients, with Propofol showing a more pronounced 
respiratory depressive effect than isoflurane or sevoflu-
rane [89]. However, the level of sedation needed to obtain 
a significant impact of such mediations on the respiratory 
drive might be too deep to be clinically acceptable.
Dexmedetomidine has recently emerged as an alter-
native drug for awake sedation with the potential of 
reducing the incidence of delirium. However, dexme-
detomidine does not affect the hypercapnic ventilatory 
response in healthy volunteers [90] and does not modify 
respiratory rate and gas exchanges in ICU patients com-
pared to placebo [91].
Benzodiazepines are associated with many adverse 
effects in ICU patients and may be inferior to other seda-
tives, as suggested by multiple clinical trials [92]. Using 
benzodiazepines to suppress respiratory drive might not 
be an optimal approach in most patients.
New pharmacological perspectives
Finally, a recent study suggested that partial muscular 
paralysis by low-dose neuromuscular blocking agents 
could obtain protective tidal volumes and inspiratory 
pressures in patients with acute respiratory failure and 
uncontrolled high respiratory drive during assisted ven-
tilation [52]. However, it is important to note that the use 
of neuromuscular blocking agents will induce a sudden 
uncoupling between respiratory drive and muscular effi-
ciency and its impact on the respiratory drive and patient 
comfort needs to be better assessed and understood.
Non‑pharmacological interventions
Future development of control of respiratory drive in 
hypoxemic patients might be related to non-pharmaco-
logical interventions such as targeted music therapy and 
extracorporeal  CO2 removal  (ECCO2R). Previous studies 
have described possible feed forward interaction between 
music rhythm and the breathing pattern of healthy and 
ICU subjects: this generates the fascinating hypothesis 
that music could act as a modulator of respiratory drive 
[93], potentially able to override metabolic inputs by 
decreasing stress and anxiety and increasing comfort (i.e., 
decreasing the behavioural drive) [94].
ECCO2R decreases the amount of  CO2 that must be 
eliminated through the lungs: this, rather than modify-
ing the brain neural drive, will simply move the meta-
bolic hyperbola downward, thus reducing the actual 
 PaCO2 and minute ventilation level. In the case of sta-
ble subjects recovering from ARDS, in whom the slope 
of brain drive is less steep and the metabolic hyperbola 
closer to healthy subjects, the decrease of  VCO2 through 
the natural lung by  ECCO2R decreases ventilation to 
minimal levels [95]. In the most severe patients with 
extremely high respiratory drive and with the metabolic 
hyperbola significantly shifted upward, efficacy of ven-
tilation reduction by  ECCO2R should be more limited, 
as indicated by pilot data [96]. Moreover, to date, the 
burden of  ECCO2R-related complications is too high to 
consider the control of respiratory drive an indication 
for its use, in non-intubated patients with less severe 
ARDS. As  ECCO2R systems become safer with advances 
in the technology, and the risk-to-benefit ratio improves, 
 ECCO2R might become a more attractive method of con-
trolling respiratory drive and avoiding further lung injury 
in patients with ARDS.
Conclusions
Respiratory drive may represent a unique synthesis of 
complex pathophysiologic mechanisms underlying and 
accompanying ARDS. Higher drive not only may cor-
relate with ARDS severity but, if not carefully managed, 
could contribute to lung and diaphragm injury. Thus, 
monitoring of the respiratory drive and interventions 
able to confine its effects within physiologic limits should 
be top priorities for the ICU physician caring for subjects 
with ARDS.
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